ID   CHD-1
AC   CVCL_EP71
SY   CHD1
DR   cancercelllines; CVCL_EP71
DR   ColonAtlas; CHD1
DR   Cosmic; 1849336
DR   Wikidata; Q54811760
RX   PubMed=8168998;
RX   PubMed=22808230;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=22808230).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
RX   PubMed=8168998; DOI=10.1002/ijc.2910570314;
RA   Moller P., Koretz K., Leithauser F., Bruderlein S., Henne C.,
RA   Quentmeier A., Krammer P.H.;
RT   "Expression of APO-1 (CD95), a member of the NGF/TNF receptor
RT   superfamily, in normal and neoplastic colon epithelium.";
RL   Int. J. Cancer 57:371-377(1994).
//
RX   PubMed=22808230; DOI=10.1371/journal.pone.0040671; PMCID=PMC3393686;
RA   Steinestel K., Bruderlein S., Steinestel J., Markl B., Schwerer M.J.,
RA   Arndt A., Kraft K., Propper C., Moller P.;
RT   "Expression of Abelson interactor 1 (Abi1) correlates with
RT   inflammation, KRAS mutation and adenomatous change during colonic
RT   carcinogenesis.";
RL   PLoS ONE 7:e40671.1-e40671.12(2012).
//